Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Early Release

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Issues Available

Volume 30, Number 6—June 2024

Perspective
  • Decolonization and Pathogen Reduction to Prevent Antimicrobial Resistance and Healthcare-Associated Infections
    M. R. Mangalea et al.
Synopses
  • Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France
    C. Vignals et al.
  • An Electronic Health Record–Based Algorithm for Respiratory Virus–like Illness
    N. M. Cocoros et al.
  • Severe Human Parainfluenza Virus Community- and Healthcare-Acquired Pneumonia in Adults at Tertiary Hospital in Seoul, South Korea, 2010–2019
    J. H. Park et al.
Research
  • SARS-CoV-2 Disease Severity in Children during Pre-Delta, Delta, and Omicron Periods, Colorado
    L. Bankers et al.
  • Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Pneumococcal Disease in Follow-Up Study, Denmark
    K. Nielsen et al.
  • Chest Radiograph Screening for Detection of Subclinical Tuberculosis in Asymptomatic Household Contacts, Peru
    Q. Tan et al.
  • Outbreak of Highly Pathogenic Avian Influenza Virus H5N1 in Seals in the St. Lawrence Estuary, Quebec, Canada
    S. Lair et al.
  • Carbapenem-Resistant and Extended-Spectrum β-Lactamase–Producing Enterobacterales Cases among Children, United States, 2016–2020
    H. N. Grome et al.
Dispatches
  • Antibodies to H5N1 Influenza A Virus in Retrieving Hunting Dogs, Washington State, USA
    J. D. Brown et al.
  • Evolution and Antigenic Differentiation of Avian Influenza A(H7N9) Virus, China
    Y. Liu et al.

    We characterized the evolution and molecular characteristics of avian influenza A(H7N9) viruses isolated in China during 2021–2023. We systematically analyzed the 10-year evolution of the hemagglutinin gene to determine the evolutionary branch. Our results showed recent antigenic drift, providing crucial clues for updating the H7N9 vaccine and disease prevention and control.

  • Burkholderia semiarida as Cause of Recurrent Pulmonary Infection in Immunocompetent Patient, China
    D. Kuang et al.
  • SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020–2023
    D. Cano-Terriza et al.
  • Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence in Persons 0–101 Years of Age, Japan, 2023
    R. Kinoshita et al.
  • Zoonotic Ancylostoma ceylanicum Infection in Coyotes from the Guanacaste Conservation Area, Costa Rica, 2021
    P. A. Zendejas-Heredia et al.
  • Detection of Encephalitozoon cuniculi in Cerebrospinal Fluid from Immunocompetent Patients, Czech Republic
    B. Sak et al.
  • Emergence of Group B Streptococcus Disease in Pigs and Porcupines, Italy
    C. Garbarino et al.
  • Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess
    S. Gourav et al.
  • Autochthonous Plasmodium vivax Infections, Florida, USA, 2023
    A. Muneer et al.

    During May–July 2023, a cluster of 7 patients at local hospitals in Florida, USA, received a diagnosis of Plasmodium vivax malaria. Whole-genome sequencing of the organism from 4 patients and phylogenetic analysis with worldwide representative P. vivax genomes indicated probable single parasite introduction from Central/South America.

Research Letters
  • Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine
    X. Nguyenla et al.

    Because novel SARS-CoV-2 variants continue to emerge, immunogenicity of XBB.1.5 monovalent vaccines against live clinical isolates needs to be evaluated. We report boosting of IgG (2.1×), IgA (1.5×), and total IgG/A/M (1.7×) targeting the spike receptor-binding domain and neutralizing titers against WA1 (2.2×), XBB.1.5 (7.4×), EG.5.1 (10.5×), and JN.1 (4.7×) variants.

  • Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan
    A. Doi et al.

    Using the GISAID EpiCoV database, we identified 256 COVID-19 patients in Japan during March 31–December 31, 2023, who had mutations in the SARS-CoV-2 nonstructural protein 5 conferring ensitrelvir resistance. Ongoing genomic surveillance is required to monitor emergence of SARS-CoV-2 mutations that are resistant to anticoronaviral drugs.

  • Novel Avian Influenza A(H5N6) in Wild Birds, South Korea, 2023
    A. Cho et al.

Top

Volume 30, Number 7—July 2024

Dispatch
  • Borrelia miyamotoi-associated Acute Meningoencephalitis, Minnesota, United States
    J. M. Kubiak et al.
Research Letter
  • Pasteurella bettyae Infections in Men Who Have Sex With Men, France
    A. Li et al.

Top

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external